Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
Bellevue Group (0QLZ) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Bellevue Group £5.06, price £7.12, upside -28.9%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? No
- Good quality? Yes
- Add to watchlist
BG
Some data
Sep 24, 2026
Bellevue Group
0QLZ · LSEOvervalued / MonitorQuality is not strong enough to offset the price risk.
!Fair value £5.06 · Overvalued (−28.9%)
✓Quality 65/100
!Weak Growth (revenue 5y −13.7 %/yr)
!Thin margins · 3.6% net margin (TTM)
✓generates free cash flow
✓2.1% dividend yield · Well covered
!Narrow moat 35/100
!Evidence only medium, so the estimate is less certain
Watch Bellevue Group for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
Pro now: $1 first month
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range £6.78 – £45.39 · the £7.12 price screens above the £5.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Company profile
Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional.
Show more
Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid-caps, and private equity strategies; and multi asset and bond solutions. The company was founded in 1993 and is headquartered in Zurich, Switzerland.
Stock analysis
Bellevue Group (0QLZ) currently trades at £7.12, while our model-based Fair Value estimate is £5.06, 28.9% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of £10.17 per share, and 4 of the 12 models we run sit above the £7.12 price.
Bear case: the Earnings-Based group reads lowest at £1.17, and 8 of the 12 models stay below the price. Evidence for this calculation is medium.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Financial Services sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Bellevue Group reported revenue of £53.0M in FY2025 versus £142M in FY2021, a compound −21.9%/yr. Reported net income was £1.9M in FY2025, compounding −57.3%/yr from FY2021.
Key figures
Market cap £112M · P/E ratio 0.0 · EPS (TTM) £3.24 · Dividend yield 2.1% · Net margin 3.6% · Return on equity 1.6% · Return on assets (EBIT) 13.0% · Operating margin 11.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −15% fair-value upside, at −29%, 0QLZ screens richer than that median.
Fair Value models
Bear £5.06
Fair Value £5.06
Bull £5.06
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (£2.33 per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Growth DCF
£13.06
£15.57
£19.30
77
Residual Income
£5.54
£5.20
£4.96
76
Owner Earnings
£5.40
£6.14
£7.34
75
All 12 models by family
DCF Models
Owner Earnings
£5.40
£6.14
£7.34
75
5Y P/E Exit
£8.03
£8.80
£9.77
69
10Y P/E Exit
£10.27
£10.97
£11.53
63
Earnings-Based
Graham-Dodd
£0.9600
£1.17
£1.32
67
Dividend Discount
Gordon GGM
£4.84
£5.17
£5.66
69
DDM Multi-Stage
£4.84
£5.60
£6.55
67
Multiples
P/E Multiple
£1.37
£1.83
£2.29
63
P/B Multiple
£1.80
£2.39
£2.99
55
Asset-Based
NCAV (Graham)
£4.37
£5.85
£8.73
51
Growth DCF
Growth DCF
£13.06
£15.57
£19.30
77
Rev-Margin DCF
£8.65
£10.17
£12.19
71
Economic Profit
Residual Income
£5.54
£5.20
£4.96
76
Notify me when 0QLZ reaches fair value
Put 0QLZ on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
65/100
Of which business quality 67 · Market factors (momentum, volatility) 37
Profitability
28
Margins and returns on capital today
Quality Growth
1
Are margins and returns improving?
Cashflow
100
Earnings quality: real cash, not paper profit
Fin. Strength
93
Balance sheet, leverage, solvency risk
Investment
100
Disciplined investing over empire-building
Low Volatility
58
Calm price path (market factor)
Momentum
34
Price trend over the last 3–12 months (market factor)
52W Momentum
18
Distance to the 52-week high (market factor)
Net Issuance
78
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−26.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−18.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.7%
Start year 2020 (pandemic). Over 10 years: −3.8% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−44.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−46.1%
Dividend (yield on the price)2.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−46.1% vs −17.7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.38% → 7%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−35.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about −36.4% a year for the price.
0QLZ screens overvalued: fair value 29% below the price. Compare with Blackstone Inc →
Compare Bellevue Group with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 647 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation Multiplesvs Asset Management median · lower = cheaper
Context: sector, industry, market
- Is the Financials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: UK Stocks
- Valuation of the UK market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Blackstone Inc BX | $112.09 | $52.29 | −53% |
| KKR & Co KKR | $93.18 | $29.26 | −69% |
| Brookfield Corporation BN | $36.87 | $13.45 | −64% |
| Apollo Global Management, Inc APO | $116.06 | $197.23 | +70% |
| State Street Corporation STT | $177.78 | $139.37 | −22% |
| Ameriprise Financial, Inc AMP | $494.82 | $595.40 | +20% |
| Ares Management Corporation ARES | $122.01 | $103.68 | −15% |
| Northern Trust Corporation NTRS | $175.73 | $123.42 | −30% |
| Raymond James Financial, Inc RJF | $161.16 | $317.27 | +97% |
| Exor N.V EXO | €68.10 | €136.20 | +100% |
Explore undervalued stocks
More undervalued Financial Services stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Bellevue Group (0QLZ) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of £5.06 versus a price of £7.12, about −29% upside (overvalued).
What is the fair value of 0QLZ?
Our model-based fair value for Bellevue Group is £5.06 (as of Sep 24, 2026), built from audited fundamentals. The current price: £7.12.
What is the quality score of 0QLZ?
Bellevue Group has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bellevue Group (0QLZ)?
Our model-based price target is the fair value of £5.06 (as of Sep 24, 2026) from 12 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Bellevue Group stock forecast for 2026?
Our models put fair value at £5.06, about −29% upside versus a price of £7.12 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Bellevue Group (0QLZ)?
Bellevue Group reported trailing-twelve-month revenue of about £52.8M (latest available figure, as of Sep 24, 2026).
Does Bellevue Group pay a dividend?
Bellevue Group currently shows a dividend yield of about 2.11% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Bellevue Group (0QLZ)?
For today's price to be fair in a discounted-cash-flow model, Bellevue Group would have to grow free cash flow by -35.0 % per year for five years (discount rate 12.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -13.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 0QLZ use?
Our models discount Bellevue Group at 12.9 %: a base by market capitalisation (micro), damped by beta 0.87, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Bellevue Group that is -35.0 % per year a year over ten years, using the same discount rate (12.9 %) and the same formula as our fair value.
How much growth has Bellevue Group (0QLZ) delivered so far?
Over the past 5 years revenue at Bellevue Group grew -13.7 % a year. The price currently implies -35.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Bellevue Group (0QLZ) growing?
The median revenue growth in the sector is +7.0 % a year. That is the yardstick for the growth priced into Bellevue Group (-35.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Bellevue Group (0QLZ)?
The free-cash-flow yield on the price is 19.92 %: that much free cash flow Bellevue Group produces per unit of market value. When it exceeds the discount rate of our models (12.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Bellevue Group (0QLZ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bellevue Group it is £5.06 per share (as of Sep 24, 2026), against a price of £7.12. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is Bellevue Group stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0QLZ trades above its calculated fair value: price £7.12, fair value £5.06, a gap of about −29% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0QLZ?
No. The price is what the market pays today (£7.12); the fair value is what the company's own numbers justify (£5.06). For Bellevue Group the two are £2.06 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bellevue Group worth?
The market values Bellevue Group at about £112M (market capitalisation, as of Sep 24, 2026). Per share that is £7.12; our models calculate a fair value of £5.06 per share.
What is the P/E ratio of 0QLZ?
Bellevue Group trades at a price-to-earnings ratio of 0.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of £5.06 is built from several models across several years.
How solid is the balance sheet of Bellevue Group (0QLZ)?
Balance-sheet figures for Bellevue Group (as of Sep 24, 2026): return on equity 1.6%. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is 0QLZ from its 52-week high?
Bellevue Group trades at £7.12, about 42% below its 52-week high of £12.29 and 5% above the low of £6.78 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of £5.06 is for.
Which stocks are comparable to Bellevue Group?
From the same area (Financial Services) we also value Blackstone Inc, KKR & Co, Brookfield Corporation, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bellevue Group stock attractive at the current price?
The data as of Sep 24, 2026: price £7.12, calculated fair value £5.06 (−29%), Quality Score 65/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0QLZ calculated?
We run Bellevue Group through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of £5.06, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Bellevue Group itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bellevue Group (0QLZ)?
The closing price on Oct 1, 2026 was £7.12. Our model-based fair value is £5.06, about −29% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bellevue Group right now?
The price sits above even our optimistic bull case (£5.06). The favourable scenario is already priced in. Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Bellevue Group (0QLZ) come from?
Earnings per share at Bellevue Group grew −4.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share −0.6 %, EBIT margin +0.0 %, tax rate +2.3 %, residual (interest, one-offs) −5.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Bellevue Group
How large is the market capitalisation of Bellevue Group (0QLZ)?
The market capitalisation of Bellevue Group is £112M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Bellevue Group (0QLZ)?
Earnings per share at Bellevue Group are £3.24 (price ÷ EPS = P/E 0.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Bellevue Group (0QLZ)?
The dividend yield of Bellevue Group is 2.1% (payout 4.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Bellevue Group (0QLZ)?
The net margin of Bellevue Group is 3.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bellevue Group (0QLZ)?
The return on equity (ROE) of Bellevue Group is 1.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bellevue Group (0QLZ)?
On an EBIT basis the return on assets of Bellevue Group is 13.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bellevue Group (0QLZ)?
The operating margin of Bellevue Group is 11.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bellevue Group (0QLZ)?
Revenue at Bellevue Group is growing −17.9% versus a year earlier (3y avg −18.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bellevue Group (0QLZ)?
Earnings per share at Bellevue Group are growing −2.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Bellevue Group (0QLZ) hold?
Bellevue Group holds more cash than debt, £1.9M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Bellevue Group in the live analysis
One click puts Bellevue Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.